Cosciens Biopharma Inc (0UGB)
LSE
Fin d'année 31 Décembre 2023 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Return on Assets (%) | -60.029 | -62.376 | 17.739 | -26.858 | -17.877 | -14.258 | -33.391 | -35.58 |
Return on Equity (%) | -179.387 | -979.644 | -955.936 | 2173.381 | -95.236 | -25.282 | -51.209 | -61.336 |
Return on Invested Capital (%) | -225.467 | 2338.983 | -179.805 | 1181.547 | -133.614 | -16.109 | -29.028 | -68.039 |
Operating Margin (%) | -2739.737 | -2196.641 | 35.858 | -1059.586 | -109.173 | -160.76 | -402.908 | -367.986 |
Net Profit Margin (%) | -2739.737 | -1819.718 | 15.576 | -1135.714 | -140.142 | -159.087 | -402.961 | -367.986 |
Book Value Per Share | -0.014 | -0.107 | -0.059 | -0.095 | 0.028 | 0.208 | 0.374 | 0.19 |
Earnings Per Share | -0.241 | -0.157 | 0.039 | -0.055 | -0.033 | -0.039 | -0.238 | -0.173 |
Cash Per Share | 0.212 | 0.073 | 0.135 | 0.071 | 0.158 | 0.308 | 0.529 | 0.356 |
Working Capital Per Share | 0.179 | 0.034 | 0.099 | 0.047 | 0.149 | 0.297 | 0.507 | 0.333 |
Operating Profit Per Share | -0.196 | -0.118 | 0.231 | 0.002 | 0.011 | 0.024 | 0.058 | 0.046 |
EBIT Per Share | -0.241 | -0.189 | 0.09 | -0.056 | -0.031 | -0.04 | -0.238 | -0.173 |
EBITDA Per Share | -0.241 | -0.189 | 0.09 | -0.056 | -0.031 | -0.04 | -0.238 | -0.173 |
Free Cash Flow Per Share | -0.242 | -0.158 | 0.039 | -0.057 | -0.035 | -0.037 | -0.239 | -0.175 |
Fin d'année 31 Décembre 2023 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Actions en circulation | 12,92M | 16,44M | 16,44M | 20M | 62,68M | 121,4M | 4,86M | 4,86M |
Capitalisation boursière | 7,92M |
Ratio cours/bénéfice | -1,19 |
Ratio prix/ventes | 4,36 |
Ratio prix/liquidités | 0,58 |
Ratio prix/valeur comptable | 1,08 |
Rendement de dividende | - |
Actions en circulation | 4,86M |
Volume moyen (1 semaine) | 0 |
Volume moyen (1 mois) | 0 |
Variation sur 52 semaines | 0,01% |
Plus haut sur 52 semaines | 1,6316 |
Plus bas sur 52 semaines | 1,6313 |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales